Long-term administration of medroxyprogesterone acetate (MPA) to acromegalic patients.
D000085:Acetates; D000172:Acromegaly / Q000097:blood / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000378:metabolism / Q000494:pharmacology; D001322:Autoanalysis; D003124:Colorimetry; D005215:Fasting; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors
D000085:Acetates; D007328:Insulin; D013006:Growth Hormone; D001120:Arginine; D008525:Medroxyprogesterone